Cargando…

First Description of Reduced Pyruvate Dehydrogenase Enzyme Activity Following Subarachnoid Hemorrhage (SAH)

Object: Several previous studies reported metabolic derangements and an accumulation of metabolic products in the early phase of experimental subarachnoid hemorrhage (SAH), which may contribute to secondary brain damage. This may be a result of deranged oxygen utilization due to enzymatic dysfunctio...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lilla, Nadine, Füllgraf, Hannah, Stetter, Christian, Köhler, Stefan, Ernestus, Ralf-Ingo, Westermaier, Thomas
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2017
Materias:	Neuroscience
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5306203/ https://www.ncbi.nlm.nih.gov/pubmed/28261039 http://dx.doi.org/10.3389/fnins.2017.00037

Ejemplares similares

Magnesium Protects in Episodes of Critical Perfusion after Aneurysmal SAH
por: Kunze, Ekkehard, et al.
Publicado: (2018)

Neuroprotective Strategies in Aneurysmal Subarachnoid Hemorrhage (aSAH)
por: Weiland, Judith, et al.
Publicado: (2021)

Therapeutic hypercapnia for prevention of secondary ischemia after severe subarachnoid hemorrhage: physiological responses to continuous hypercapnia
por: Stetter, Christian, et al.
Publicado: (2021)

Brain edema formation correlates with perfusion deficit during the first six hours after experimental subarachnoid hemorrhage in rats
por: Westermaier, Thomas, et al.
Publicado: (2012)

Early Antiinflammatory Therapy Attenuates Brain Damage After Sah in Rats
por: Vadokas, Georg, et al.
Publicado: (2019)

Analysis of cerebral glucose metabolism following experimental subarachnoid hemorrhage over 7 days
por: Schadt, Fabian, et al.
Publicado: (2023)

Value of Perfusion CT, Transcranial Doppler Sonography, and Neurological Examination to Detect Delayed Vasospasm after Aneurysmal Subarachnoid Hemorrhage
por: Kunze, Ekkehard, et al.
Publicado: (2012)

Inflammatory Events Following Subarachnoid Hemorrhage (SAH)
por: Schneider, U.C., et al.
Publicado: (2018)

Investigating the relationship between high-dose norepinephrine administration and the incidence of delayed cerebral infarction in patients with aneurysmal subarachnoid hemorrhage: A single-center retrospective evaluation
por: Cattaneo, Andrea, et al.
Publicado: (2023)

Case Report: A Case Series Using Natural Anatomical Gaps—Posterior Cervical Approach to Skull Base and Upper Craniocervical Meningiomas Without Bone Removal
por: Lilla, Nadine, et al.
Publicado: (2021)

Multidrug-resistant organisms (MDROs) in patients with subarachnoid hemorrhage (SAH)
por: Rhim, Ha-Young, et al.
Publicado: (2021)

Acute Multidisciplinary Management of Aneurysmal Subarachnoid Hemorrhage (aSAH)
por: Ran, Kathleen R, et al.
Publicado: (2023)

Magnesium treatment for neuroprotection in ischemic diseases of the brain
por: Westermaier, Thomas, et al.
Publicado: (2013)

Initial severity of aneurysmal subarachnoid hemorrhage (SAH): Trend over time
por: Sung, Seung Bin, et al.
Publicado: (2022)

Follow-up of Vasospasm by Transcranial Doppler Sonography (TCD) in Subarachnoid Hemorrhage (SAH)
por: Djelilovic-Vranic, Jasminka, et al.
Publicado: (2017)

Exome sequencing study revealed novel susceptibility loci in subarachnoid hemorrhage (SAH)
por: Hao, Xiwa, et al.
Publicado: (2020)

Differential polarization and activation dynamics of systemic T helper cell subsets after aneurysmal subarachnoid hemorrhage (SAH) and during post-SAH complications
por: Chaudhry, Shafqat Rasul, et al.
Publicado: (2021)

Outcomes of spontaneous subarachnoid hemorrhage (sah) in neurocritical care unit: a multicenter study
por: Iglesias Posadilla, D, et al.
Publicado: (2015)

Janus Faced HMGB1 and Post-Aneurysmal Subarachnoid Hemorrhage (aSAH) Inflammation
por: Chaudhry, Shafqat Rasul, et al.
Publicado: (2022)

Clustering of serum biomarkers involved in post-aneurysmal subarachnoid hemorrhage (aSAH) complications
por: Fischer, Igor, et al.
Publicado: (2023)

3D rotational fluoroscopy for intraoperative clip control in patients with intracranial aneurysms – assessment of feasibility and image quality
por: Westermaier, Thomas, et al.
Publicado: (2016)

Primary Spinal Glioblastoma Multiforme with Secondary Manifestation as a Cerebral “Angioglioma.” Literature Review and Case Report
por: Linsenmann, Thomas, et al.
Publicado: (2015)

Role of Damage Associated Molecular Pattern Molecules (DAMPs) in Aneurysmal Subarachnoid Hemorrhage (aSAH)
por: Chaudhry, Shafqat Rasul, et al.
Publicado: (2018)

Serum concentration–guided intravenous magnesium sulfate administration for neuroprotection in patients with aneurysmal subarachnoid hemorrhage: a retrospective evaluation of a 12-year single-center experience
por: Wipplinger, C., et al.
Publicado: (2023)

Changes in the C-type Natriuretic peptide (CNP) and NO derivatives in the plasma and CSF of the patients with subarachnoid hemorrhage (SAH)
por: Ikeda, K, et al.
Publicado: (2000)

Microglia as target for anti-inflammatory approaches to prevent secondary brain injury after subarachnoid hemorrhage (SAH)
por: Heinz, Rebecca, et al.
Publicado: (2021)

Role of pyruvate dehydrogenase complex in traumatic brain injury and Measurement of pyruvate dehydrogenase enzyme by dipstick test
por: Sharma, Pushpa, et al.
Publicado: (2009)

Should endovascular therapy for cerebral vasospasm coincide with hypervolemic-hypertensive therapy (HT) in aneurysmal subarachnoid hemorrhage (SAH)?
por: Liopyris, P, et al.
Publicado: (1999)

Monitoring of hypervolemic hemodilution and hypertensive (HHH) therapy in subarachnoid hemorrhage (SAH) patients with pulmonary artery catheter (PAC)
por: Nates, JL, et al.
Publicado: (1998)

Elevated Systemic IL-6 Levels in Patients with Aneurysmal Subarachnoid Hemorrhage Is an Unspecific Marker for Post-SAH Complications
por: Chaudhry, Shafqat Rasul, et al.
Publicado: (2017)

Intracranial Venous Alteration in Patients With Aneurysmal Subarachnoid Hemorrhage: Protocol for the Prospective and Observational SAH Multicenter Study (SMS)
por: Umana, Giuseppe E., et al.
Publicado: (2022)

TLR4-Pathway-Associated Biomarkers in Subarachnoid Hemorrhage (SAH): Potential Targets for Future Anti-Inflammatory Therapies
por: Heinz, Rebecca, et al.
Publicado: (2022)

Inflammation and immune cell abnormalities in intracranial aneurysm subarachnoid hemorrhage (SAH): Relevant signaling pathways and therapeutic strategies
por: Jin, Jing, et al.
Publicado: (2022)

Elevated Level of Cerebrospinal Fluid Pyruvate Dehydrogenase Kinase 4 Is a Predictive Biomarker of Clinical Outcome after Subarachnoid Hemorrhage
por: Gao, Xuan, et al.
Publicado: (2022)

Development of a patient-reported outcome measure for patients who have recovered from a subarachnoid hemorrhage: the “questionnaire for the screening of symptoms in aneurysmal subarachnoid hemorrhage” (SOS-SAH)
por: Nobels-Janssen, Edith, et al.
Publicado: (2021)

Magnesium Levels and Diastolic Blood Pressure (DBP) as a Vasospasm Prediction Metric in Patients With Aneurysmal Subarachnoid Hemorrhage (SAH)
por: Savla, Paras, et al.
Publicado: (2022)

Recurrent spreading depolarizations after subarachnoid hemorrhage decreases oxygen availability in human cerebral cortex
por: Bosche, Bert, et al.
Publicado: (2010)

Elevated Systemic IL-10 Levels Indicate Immunodepression Leading to Nosocomial Infections after Aneurysmal Subarachnoid Hemorrhage (SAH) in Patients
por: Chaudhry, Shafqat Rasul, et al.
Publicado: (2020)

Burden of disease and costs of aneurysmal subarachnoid haemorrhage (aSAH) in the United Kingdom
por: Rivero-Arias, Oliver, et al.
Publicado: (2010)

Low albuminemia on vasospasm following subarachinoid hemorrhage (SAH)
por: Ikeda, K, et al.
Publicado: (1998)

Cannot write session to /tmp/vufind_sessions/sess_jme67r0pvrsfr3254m03sha2i6